Publications

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.

Authors: KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, JR Hansford, K...

E-pub date: 1 Jan 2017

Journal name: Acta Neuropathol

Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis.

Authors: S Sivakumar, I de Santiago, L Chlon, F Markowetz

E-pub date: 1 Jan 2017

Journal name: PLoS Med

Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

Authors: E Sala, E Mema, Y Himoto, H Veeraraghavan, JD Brenton, A Snyder, B Weigelt,...

E-pub date: 1 Jan 2017

Journal name: Clin Radiol

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Authors: EM Swisher, KK Lin, AM Oza, CL Scott, H Giordano, J Sun, GE Konecny, RL Col...

E-pub date: 1 Jan 2017

Journal name: Lancet Oncol

Deciphering the divergent roles of progestogens in breast cancer.

Authors: JS Carroll, TE Hickey, GA Tarulli, M Williams, WD Tilley

E-pub date: 1 Jan 2017

Journal name: Nat Rev Cancer

MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporter.

Authors: F Schilling, S Ros, D-E Hu, P D'Santos, S McGuire, R Mair, AJ Wright, E Man...

E-pub date: 1 Jan 2017

Journal name: Nat Biotechnol

Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories

Authors: T Forshew, A Lawson, S Smalley, V Plagnol, J Calaway, S Blais, K Howarth, G...

E-pub date: 1 Jan 2017

Journal name: Journal of Thoracic Oncology

Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients

Authors: J Remon, C Caramella, C Joelet, L Lacroix, A Lawson, S Smalley, K Howarth, ...

E-pub date: 1 Jan 2017

Journal name: Journal of Thoracic Oncology

Filters

Research Groups

Core Facilities

Start date

End date

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.

Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis.

Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Deciphering the divergent roles of progestogens in breast cancer.

MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporter.

Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories

Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients

Themes

Filters

Research Groups

Core Facilities

Start date

End date

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.

Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis.

Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Deciphering the divergent roles of progestogens in breast cancer.

MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporter.

Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories

Osimertinib Benefit in ctDNA T790M Positive, EGFR-Mutant NSCLC Patients